Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review

Evidence suggests that combined gemcitabine-cisplatin chemotherapy extends survival in patients with advanced biliary tract cancer (BTC). We conducted a systematic review in order to collate this evidence and assess whether gemcitabine-cisplatin efficacy is influenced by primary tumor site, disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Joon Oh, Oh, Do-Youn, Hsu, Chiun, Chen, Jen-Shi, Chen, Li-Tzong, Orlando, Mauro, Kim, Jong Seok, Lim, Ho Yeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509359/
https://www.ncbi.nlm.nih.gov/pubmed/25989801
http://dx.doi.org/10.4143/crt.2014.308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509359/
https://www.ncbi.nlm.nih.gov/pubmed/25989801
http://dx.doi.org/10.4143/crt.2014.308

Ejemplares similares